Drugs Made In America Acquisition II Corp. (DMII) Income Statement

1 Followers

Drugs Made In America Acquisition II Corp. Income Statement

Last quarter (Q3 2025), Drugs Made In America Acquisition II Corp.'s total revenue was $0.00. In Q3, Drugs Made In America Acquisition II Corp.'s net income was $-46.16K. See Drugs Made In America Acquisition II Corp.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24
Total Revenue	$ 0.00
Gross Profit	$ 0.00
Operating Expenses	$ 151.72K
Depreciation and Amortization	$ 0.00
EBITDA	$ -151.72K
Operating Income	$ -151.72K
Other Income/Expenses	$ 0.00
Pretax Income	$ -151.72K
Net Income	$ -151.72K
Per Share Metrics
Basic EPS	$ 0.00
Diluted EPS	$ 0.00
Weighted Average Shares Outstanding	63.70M
Weighted Average Shares Outstanding (Diluted)	63.70M

Currency in USD

Drugs Made In America Acquisition II Corp. (DMII) Income Statement

Drugs Made In America Acquisition II Corp. Income Statement

Drugs Made In America Acquisition II Corp. Earnings and Revenue History